NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.770
0.00 (0.00%)
At close: Jul 24, 2026, 4:00 PM EDT
1.833
+0.063 (3.54%)
After-hours: Jul 24, 2026, 7:34 PM EDT
NovaBridge Biosciences Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, NovaBridge Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $8.00. The average 1-year stock price forecast is 351.98% higher than the current stock price, while the lowest is $7.00 (+295.48%) and the highest is $9.00 (+408.47%).
Price Target: $8.00 (+351.98%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on May 26, 2026.
Analyst Ratings
The average analyst rating for NovaBridge Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $9 | Buy | Maintains | $9 | +408.47% | May 26, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.94
from -0.48
EPS Next Year
-1.06
from -0.94
EPS and Forward PE are based on non-GAAP adjusted numbers.